Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an earlier version of the legal challenge.

A Texas federal judge Thursday ruled Idaho, Kansas, and Missouri can join a case challenging access to the abortion pill. Trump-appointed Judge Matthew Kacsmaryk allowed the states to pursue legal action in Texas that seeks to prohibit the Food and Drug Administration (FDA) from allowing online prescriptions for Mifepristone over concerns that it could “undermine state abortion laws and frustrate state law enforcement,

Small studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity disorder symptoms in kids.

Three Republican-led states will be allowed to move forward with a lawsuit to restrict access to mifepristone, a Texas federal judge ruled Thursday, months after the Supreme Court rejected an

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide

VisiRose Inc. (”VisiRose” or the “Company”), a privately-held, clinical-stage biotechnology company developing novel ocular therapeutics, today announced a $3 million seed financing round for VisiRose.

The proposed "at-a-glance" label would prominently show whether foods contain low, medium or high levels of saturated fat, sodium and added sugars.

Efforts to limit access to the abortion drug mifepristone have received a boost from a federal judge who took the bench during President Donald Trump's first term.

Idaho, Kansas and Missouri can pursue legal action to prohibit the Food and Drug Administration from allowing online prescriptions.

As President Donald Trump begins his second term, the landscape around reproductive health in the United States is dramatically different from when he first took office in 2017. Trump appointed three U.

Schweitzer Engineering Labs enters the medical field with a handheld device that detects autism early, giving children crucial years for intervention.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.